Effect of removal of AuraOnce™ laryngeal mask in awake or deep anaesthesia: a randomized controlled trial

The manufacturer Ambu® recommends that the AuraOnce™ laryngeal mask be removed once the patient is fully awake. Studies have shown benefit in removal of the laryngeal mask airway while a patient is deeply anaesthetized. Current evidence is inconclusive, as to which approach is preferable and safer i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:African health sciences 2019-12, Vol.19 (4), p.2954-2963
Hauptverfasser: Ombaka, Ronald, Mung'ayi, Vitalis, Nekyon, David, Mir, Samina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The manufacturer Ambu® recommends that the AuraOnce™ laryngeal mask be removed once the patient is fully awake. Studies have shown benefit in removal of the laryngeal mask airway while a patient is deeply anaesthetized. Current evidence is inconclusive, as to which approach is preferable and safer in adults. one hundred and sixteen adult patients were randomly assigned to two groups of 58. For the deep arm; The AuraOnce™ laryngeal mask was removed after attaining an end tidal minimum alveolar concentration of Isoflurane of 1.15%. Occurrence of airway complication(s) (One or more of the following; Airway obstruction requiring airway manipulation; Laryngospasm; Desaturation to 90% or less on pulse oximetry) was noted until the subject was fully awake (appropriate response to command) in the post-anaesthesia care unit. For the awake arm; The AuraOnce™ laryngeal mask was removed on attaining an end tidal minimum alveolar concentration of Isoflurane of
ISSN:1680-6905
1729-0503
DOI:10.4314/ahs.v19i4.16